Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 4 for:    atomoxetine and Mild cognitive impairment
Previous Study | Return to List | Next Study

Effects of Atomoxetine in Mild Cognitive Impairment (ATX-001)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Emory University
Sponsor:
Collaborator:
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Allan I Levey, MD, Emory University
ClinicalTrials.gov Identifier:
NCT01522404
First received: January 25, 2012
Last updated: June 24, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)